4th August 2020 Product update: rapidmicrobiology staff writer
LabVantage COVID-19 LIMS Solution Implemented for Onsite Workplace Health and Safety
LabVantage Solutions, Inc., a provider of laboratory informatics solutions and services including purpose-built LIMS solutions that allow labs to go live faster and at a lower total cost, have announced that a Fortune 100 global consumer packaged goods (CPG) company has deployed the LabVantage COVID-19 LIMS solution to ensure employee health and safety in the workplace.
The U.S.-based CPG company opened an in-house COVID-19 testing center where employees can quickly and safely be tested for the SARS-CoV-2 virus that causes COVID illnesses. In-house health and laboratory professionals, using LabVantage’s purpose-built COVID-19 laboratory information management system (LIMS), can quickly schedule, collect samples, test, track, and report results.
The CPG company already uses the LabVantage enterprise LIMS across areas of its organization. When LabVantage announced its new purpose-built solution specific to the COVID-19 pandemic, the company was able to implement it in under six weeks for onsite employee testing that supports a safer workplace.
“LabVantage COVID-19 LIMS is a full-featured, pre-configured solution for companies, colleges, and universities looking for a way to keep their employees and students safe in the workplace or on campus with the confidence that comes with accurate and comprehensive testing,” said LabVantage CEO, John Heiser. “It’s illustrative of our ability to transform scientific data into knowledge that drives better outcomes for our business partners.”
Having the testing process onsite saves time and gives the employees the convenience of not having to go to a hospital or doctor’s office for a test. Employees displaying symptoms, or those who request a test, can be scheduled quickly for an appointment. LabVantage COVID-19 LIMS prepares the sample request, labels sample specimens, tracks all patient and sample data following privacy and security protocols such as HIPAA and GDPR, and handles results and reporting in a single easy-to-use interface.
Dr. Heiser pointed out that the LabVantage COVID-19 LIMS solution is ideal for companies that are equipped to conduct all testing-related work in-house, as well as for organizations that do not have their own testing facilities who work with third-party laboratories. In addition, LabVantage’s ISO-27001 certification, existing validation practices, and Certificate of Release allows companies to focus their validation efforts on critical functions while still being able to confidently point to a reliable solution.
The COVID-specific LIMS solution incorporates LabVantage’s deep knowledge of laboratory workflows, along with numerous features designed to make it easy for laboratories to perform coronavirus testing using RT-PCR, isothermal nucleic acid amplification, and serology methods. LabVantage COVID-19 LIMS can be hosted on the cloud or offered as SaaS and is highly scalable, which are important attributes as testing volumes escalate.
The LabVantage COVID-19 LIMS is available immediately. For more information on LIMS for coronavirus testing, visit www.labvantage.com/your-lab-type/labvantage-covid-19-lims/
Date Published: 4th August 2020
Source article link: View
Note: This content has been edited by a rapidmicrobiology staff writer for style and content.
Quantitative RUO COVID-19 ELISA Will
FDA Recommendations for COVID-19 Diagnostics